Evidence map›Paper›PMID 35070221›Full record

ArticleHematology reports2021

Therapeutic innovation for multi-resistant candidemics: Synergy of isavuconazole and caspofungin association.

Andrea Duminuco, Elisa Mauro, Giuseppe A M Palumbo, Bruno Garibaldi, Marina Parisi, Francesco Di Raimondo, Cinzia Maugeri, Calogero Vetro

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Hematology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Emergencies in Hematology: Why, When and How I Treat?Journal of clinical medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Andrea DuminucoPost Graduation School of Hematology, University of Catania, A.O.U. 'Policlinico-San Marco', Catania.
Elisa MauroDivision of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.
Giuseppe A M PalumboDivision of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.
Bruno GaribaldiPost Graduation School of Hematology, University of Catania, A.O.U. 'Policlinico-San Marco', Catania.
Marina ParisiDivision of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.
Francesco Di RaimondoDivision of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.
Cinzia MaugeriDivision of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.
Calogero VetroDivision of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.
Policlinico Universitario di Catania · ITUniversity of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal infections occurring in immunocompromised patients after immunochemotherapy treatment are often difficult to eradicate and capable of even being fatal. Systemic mycoses affecting severely immunocompromised patients often manifest acutely with rapidly progressive pneumonia, fungemia, or manifestations of extrapulmonary dissemination. Opportunistic fungal infections (mycoses) include several pathogens elements, as candidiasis, aspergillosis, mucormycosis (zygomycosis) and fusariosis. Prompt diagnosis and effective therapy are needed to improve the associated morbidity and mortality, especially in cases with non-canonical fungal localizations and not responsive to the available antifungal drugs.

Indexed as

CandidaCaspofunginCombined antifungal therapyFungal infectionHematological patientsIsavuconazole

Identifiers

PMID35070221
PMCPMC8743983
OpenAlexW3216838428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.